Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P372
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Skarzynski, Martin
Lindorfer, Margeret
Butera, Vicent
Vire, Berengere
Farooqui, Mohammed
Rader, Christoph
Taylor, Ronald
Wiestner, Adrian
Article History
First Online: 4 November 2015